Matthew Winkler serves as Executive at Mirna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Matthew Winkler has executed 16 insider transactions totaling $1.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 8, 2025 involved transacting 984,513 shares valued at $0.
Matthew Winkler currently holds 984,513 shares of Mirna Therapeutics, Inc. (MIRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Winkler has been a net buyer of MIRN stock. They have purchased $1.0M and sold $0 worth of shares.
Matthew Winkler's most recent insider trade was on Jul 8, 2025, when they sold 984,513 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.00 |
| Discretionary |
| Oct 6, 2015 | MIRN | $0 | Other | 62,582 | $N/A | Discretionary |
| Oct 6, 2015 | MIRN | $0 | Other | 8,408 | $N/A | Discretionary |
| Oct 6, 2015 | MIRN | $0 | Other | 8,408 | $N/A | Discretionary |
| Oct 6, 2015 | MIRN | $0 | Other | 8,408 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 2,345 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 40,281 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 2,345 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 2,345 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 187,277 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 235,899 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 28,458 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 134,958 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 40,281 | $N/A | Discretionary |
| Oct 5, 2015 | MIRN | $0 | Conversion | 40,281 | $N/A | Discretionary |